Search results for: 'long test impact of evolving cloud'

The global hemoglobin A1C (HbA1c) testing market will witness significant growth driven by technological advances and the increasing adoption of point-of-care testing (POCT). Real-time glucose monitoring and conventional HbA1c testing have been integrated, revolutionizing patient care by offering better treatment choices and better results. By stre...

Frost & Sullivan’s recent global annual cloud survey’s primary goal is to determine cloud computing technology adoption among healthcare organizations, top business strategic goals, preferred cloud deployment models, information technology (IT), business challenges in cloud migration, and expansion opportunities for healthcare cloud providers. F...

23 Aug 2022  |  North America  |  Market Research

Global Bioanalytical Testing Services, 2021–2027

Acquisition of Disruptive Technologies will be the Key to Driving Growth

Infographics

×

Key Issues Addressed

As the pharma market recovers from the debilitating impact of COVID-19 on the drug discovery and development pipelines, there is an increasing requirement for outsourcing services in the form of contract research organizations (CROs) and contract development & manufacturing organizations (CDMOs), which is likely to drive the already strong drug dev...

This study provides an overview of the global point-of-care testing (POCT) industry, which refers to any routine or specialized lab pathology testing conducted rapidly, on-site/near the site of the patient, where care or treatment is provided. COVID-19 radicalization is changing the global diagnostics landscape. Consolidation trends, structural s...

This research service on the global pharmaceutical stability testing market addresses market sizing, emerging trends, and technologies, and provides a snapshot of the key participants in the market. The base year is 2015 and forecasts are provided from 2016 to 2020. The market is expected to grow at a CAGR of 9.4% till 2020, driven by an explosio...

Since the onset of the COVID-19 pandemic, molecular diagnostics mergers/acquisition transactions and product launches for infectious disease testing are indicating a pivot toward a new direction or an enhancement of portfolios. The emergence of saliva sample testing and the transition to PCR-based syndromic and direct-to-consumer testing for respir...

Retail health providers fill the traditional healthcare void by offering healthcare services, such as pharmacy, preventive care, urgent care, chronic condition management, vaccinations, telehealth, wellness, and an emerging focus on women’s health. High cost is a barrier to healthcare and medication access, affecting uninsured and aged populations ...

14 Jul 2022  |  North America  |  Market Research

United States Molecular Point-of-Care Testing Growth Opportunities

Syndromic Point-of-Care Testing Drives Transformational Growth in Infectious Disease Diagnostics

Infographics

×

Rapid advancements in infectious disease diagnostics continue with novel identification methods and healthcare accessibility improvements. The shift from traditional testing to a more technologically empowered, consumer-centric testing encompasses the sample-in-answer-out approach of diagnostic testing that generates results in minutes or hours. Nu...

Rising incidents of patient deaths are raising questions about medical device efficacy, specifically Class II and Class III medical devices. All medical devices commercialized in the US market must adhere to 510(k) compliance. The US Food and Drug Administration (FDA) posts summaries of information about the most serious medical device recalls. ...